PubMed

FDA 승인된 정형외과 장비와 그 회수 분석

PMID: 26984921 · 2016-03-16

C, h, a, r, l, e, s, , S, , D, a, y, ;, , D, a, v, i, d, , J, , P, a, r, k, ;, , F, r, e, d, e, r, i, c, k, , S, , R, o, z, e, n, s, h, t, e, y, n, ;, , N, a, n, a, , O, w, u, s, u, -, S, a, r, p, o, n, g, ;, , A, l, d, e, b, a, r, a, n, i, , G, o, n, z, a, l, e, z

학술지The Journal of bone and joint surgery. American volume

연도2016-03-16

PMID26984921

초록

The U.S. Food and Drug Administration (FDA) evaluates medical devices by two main pathways. The more stringent Premarket Approval (PMA) review requires clinical trials, and the Premarket Notification 510(k) process generally exempts devices from clinical trials if they prove to be substantially equivalent to existing devices. We hypothesized that orthopaedic devices are more likely to be cleared through the 510(k) process and thus are more susceptible to being recalled. Using the FDA's public da

공식 출처

PubMed에서 보기 →

데이터는 PubMed / NCBI에서 제공됩니다. 전문과 최신 정보는 반드시 공식 기록을 확인하세요.